Cargando…
Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma
Autores principales: | Martini, G, Falcini, F, Girschick, H, Goldsmidt, D, Zulian, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334033/ http://dx.doi.org/10.1186/1546-0096-6-S1-P229 |
Ejemplares similares
-
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020) -
Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008) -
Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011) -
Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010) -
Polyarteritis Nodosa (PAN) in childhood: a report of two siblings with intractable disease controlled by mycophenolate mofetil (MMF)
por: Falcini, FF, et al.
Publicado: (2008)